GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SHL Telemedicine Ltd (XSWX:SHLTN) » Definitions » Debt-to-EBITDA

SHL Telemedicine (XSWX:SHLTN) Debt-to-EBITDA : -19.88 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is SHL Telemedicine Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

SHL Telemedicine's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF3.97 Mil. SHL Telemedicine's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF13.20 Mil. SHL Telemedicine's annualized EBITDA for the quarter that ended in Dec. 2023 was CHF-0.86 Mil. SHL Telemedicine's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -19.88.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for SHL Telemedicine's Debt-to-EBITDA or its related term are showing as below:

XSWX:SHLTN' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -4.3   Med: 2.14   Max: 20.53
Current: 6.27

During the past 13 years, the highest Debt-to-EBITDA Ratio of SHL Telemedicine was 20.53. The lowest was -4.30. And the median was 2.14.

XSWX:SHLTN's Debt-to-EBITDA is ranked worse than
80.33% of 422 companies
in the Healthcare Providers & Services industry
Industry Median: 2.58 vs XSWX:SHLTN: 6.27

SHL Telemedicine Debt-to-EBITDA Historical Data

The historical data trend for SHL Telemedicine's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SHL Telemedicine Debt-to-EBITDA Chart

SHL Telemedicine Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.37 2.69 -4.30 2.82 6.57

SHL Telemedicine Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.62 2.85 2.91 - -19.88

Competitive Comparison of SHL Telemedicine's Debt-to-EBITDA

For the Health Information Services subindustry, SHL Telemedicine's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SHL Telemedicine's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where SHL Telemedicine's Debt-to-EBITDA falls into.



SHL Telemedicine Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

SHL Telemedicine's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.974 + 13.2) / 2.615
=6.57

SHL Telemedicine's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.974 + 13.2) / -0.864
=-19.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


SHL Telemedicine  (XSWX:SHLTN) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


SHL Telemedicine Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of SHL Telemedicine's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


SHL Telemedicine (XSWX:SHLTN) Business Description

Traded in Other Exchanges
Address
90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world.

SHL Telemedicine (XSWX:SHLTN) Headlines

No Headlines